Evidence map›Paper›PMID 28539662›Full record

SynthesisScientific reports2017

Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis.

Claudio Luchini, Achim Fleischmann, Joost L Boormans, Matteo Fassan, Alessia Nottegar, Paola Lucato, Brendon Stubbs, Marco Solmi, Antonio Porcaro, Nicola Veronese and 3 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. CanRadiation oncology (London, England) · 2020
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Deep learning-based whole-body characterization of prostate cancer lesions on [European journal of nuclear medicine and molecular imaging · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Ampulla of Vater carcinoma: Molecular landscape and clinical implications.World journal of gastrointestinal oncology · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Claudio LuchiniDepartment of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy. claudio.luchini@univr.it.ORCID 0000-0003-4901-4908
Achim FleischmannInstitute of Pathology, University of Bern, CH-3010, Bern, Switzerland.
Joost L BoormansDepartment of Urology, Erasmus MC - Cancer Institute, Rotterdam, The Netherlands.
Matteo FassanDepartment of Medicine, DIMED, University of Padua, Padua, Italy.ORCID 0000-0001-6515-5482
Alessia NottegarDepartment of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy.
Paola LucatoDepartment of Medicine, DIMED, University of Padua, Padua, Italy.
Brendon StubbsHealth Service and Population Research Department, King's College London, De Crespigny Park, London, SE5 8AF, United Kingdom.
Marco SolmiDepartment of Neuroscience, University of Padua, Padua, Italy.
Antonio PorcaroUrologic Clinic, University and Hospital trust of Verona, Verona, Italy.
Nicola VeroneseNational Research Council, Neuroscience Institute, Aging Branch, Padova, Italy.
Matteo BrunelliDepartment of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy.
Aldo ScarpaDepartment of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy.ORCID 0000-0003-1678-739X
Liang ChengDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. lcheng@iupui.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The extranodal extension (ENE) of nodal metastasis involves the extension of neoplastic cells through the lymph node capsule into the perinodal adipose tissue. This morphological feature has recently been indicated as an important prognostic factor in various cancer types, but its role in prostate cancer is still unclear. We aimed to clarify it, performing the first meta-analysis on this issue, comparing prognostic parameters in surgically treated, node-positive prostate cancer patients with (ENE+) vs. without (ENE-) ENE. Data were summarized using risk ratios (RRs) for number of deaths/recurrences and hazard ratios (HRs), with 95% confidence intervals (CI), for the time-dependent risk related to ENE positivity. Six studies followed-up 1,113 patients with N1 prostate cancer (658 ENE+ vs. 455 ENE-) for a median of 83 months. The presence of ENE was associated with a significantly higher risk of biochemical recurrence (RR = 1.15; 95%CI: 1.03-1.28; I

Indexed as

AgedHumansLymphatic MetastasisLymph NodesMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasms, Adipose TissueOdds RatioPrognosisProportional Hazards ModelsProstateProstatic Neoplasms

Identifiers

PMID28539662
PMCPMC5443831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.